Please login to the form below
Merck KGaA
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.
Merck KGaA adds two to its executive board
Merck KGaA has appointed two new members to its executive board, adding the head of its life science business sector Udit Batra (pictured right) and Walter Galinat (pictured below), who heads ... Meanwhile, Batra started his career with Merck's US
Germany's Merck triumphs in court battle with US namesake
English court rules Merck &Co breached the firms' naming agreement. Merck KGaA has reasserted its rights to the Merck name after a three-year court-room tussle with Merck &Co of ... The decision comes some three months after Merck launched an
Sanofi and Novartis snap up immuno-oncology candidates
Currently the market is being led by Bristol-Myers Squibb and Merck &Co - both with already-marketed products - with AstraZeneca (AZ), Roche and Merck KGaA/Pfizer snapping at their heels.
Syndax teams with Merck/Pfizer on immuno-oncology combo
Oral cancer drug entinostat to test with avelumab. Syndax Pharma has agreed to test its oral cancer drug entinostat with Merck KGaA and Pfizer's cancer immunotherapy avelumab in ovarian cancer. ... The drug is in the same class as Novartis' recently
Ariad appoints new CEO
Paris Panayiotopoulos joins the US biotech from EMD Serono. Paris Panayiotopoulos has moved from EMD Serono to join Ariad as its new president and CEO. ... Prior to his time at EMD Serono, where he was its president, and its parent company Merck KGaA
[ Previous 5 results ] 28 29 30 31 32 33 34 35 36 37 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- Scientists discover new approach to treat brain tumours
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure
- Assessing the value of interim analyses in clinical trials
- Why testing shouldn't be confined to the lab
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Live Webinar: Engaging Patients "Just-In-Time" with Machine Learning
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- Recognising HIV Vaccine Awareness Day
- AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
- Roche shares new positive Ocrevus data for MS patients
- How scientific storytelling can help Pharma cut through the noise
- How patient experience mapping can improve patient recruitment
- FDA approves Alexion’s Ultomiris for generalised myasthenia gravis
- Getting patients to engage with clinical trials
- Mapping patient pathways – with a focus on patient-centricity
PMHub
VISFO
A team of strategic decision specialists with over 30+ years in the pharma space, we give you confidence through experience....
Latest intelligence
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
